393 related articles for article (PubMed ID: 36077813)
1. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.
Belli C; Antonarelli G; Repetto M; Boscolo Bielo L; Crimini E; Curigliano G
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077813
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment signaling and therapeutics in cancer progression.
Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
[TBL] [Abstract][Full Text] [Related]
4. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
Guo T; Li W; Cai X
Front Genet; 2020; 11():548719. PubMed ID: 33329692
[TBL] [Abstract][Full Text] [Related]
5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
6. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
7. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
Front Immunol; 2020; 11():784. PubMed ID: 32457745
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy.
Schetters STT; Rodriguez E; Kruijssen LJW; Crommentuijn MHW; Boon L; Van den Bossche J; Den Haan JMM; Van Kooyk Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690667
[TBL] [Abstract][Full Text] [Related]
9. The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.
Gao S; Sugimura R
Cancer Treat Res; 2022; 183():275-285. PubMed ID: 35551664
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation, cancer development and immunotherapy.
Wen Y; Zhu Y; Zhang C; Yang X; Gao Y; Li M; Yang H; Liu T; Tang H
Front Pharmacol; 2022; 13():1040163. PubMed ID: 36313280
[TBL] [Abstract][Full Text] [Related]
11. Targeting immune checkpoints in hematological malignancies.
Salik B; Smyth MJ; Nakamura K
J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
[TBL] [Abstract][Full Text] [Related]
12. Structural Biology of the Tumor Microenvironment.
Freeman JW
Adv Exp Med Biol; 2021; 1350():91-100. PubMed ID: 34888845
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
14. Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer.
Lal JC; Townsend MG; Mehta AK; Oliwa M; Miller E; Sotayo A; Cheney E; Mittendorf EA; Letai A; Guerriero JL
Breast Cancer Res; 2021 Aug; 23(1):83. PubMed ID: 34353349
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Zhao Y; Shen M; Wu L; Yang H; Yao Y; Yang Q; Du J; Liu L; Li Y; Bai Y
Cell Death Dis; 2023 Sep; 14(9):587. PubMed ID: 37666813
[TBL] [Abstract][Full Text] [Related]
16. The tumor microenvironment: shaping cancer progression and treatment response.
Desai SA; Patel VP; Bhosle KP; Nagare SD; Thombare KC
J Chemother; 2024 Jan; ():1-30. PubMed ID: 38179655
[TBL] [Abstract][Full Text] [Related]
17. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
Dzobo K; Senthebane DA; Dandara C
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672326
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
19. Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.
Akinsipe T; Mohamedelhassan R; Akinpelu A; Pondugula SR; Mistriotis P; Avila LA; Suryawanshi A
Front Immunol; 2024; 15():1302587. PubMed ID: 38533507
[TBL] [Abstract][Full Text] [Related]
20. Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer.
Chaib M; Chauhan SC; Makowski L
Front Cell Dev Biol; 2020; 8():351. PubMed ID: 32509781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
